Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial.

OBJECTIVE: To assess the efficacy of the insulin pen cap Insulclock on improving glycemic control, treatment adherence, and user satisfaction in people with type 1 diabetes. RESEARCH DESIGN AND METHODS: This multicenter, open-label, randomized controlled trial comprised a 4-week run-in phase and a 6-week double-arm phase in which participants were randomly assigned into an active or masked mode. RESULTS: Fifty-five participants were evaluable (active group, n = 26, masked group, n = 29). The increase in time in range was higher in the active versus masked group (5.2% vs. -0.8%; P = 0.016). The active group showed a higher reduction in mean glucose, glucose management indicator, time above range, and high blood glucose index. On-time insulin doses increased in the active group and decreased in the masked group. CONCLUSIONS: Insulclock system use was associated with improved glycemic control, glycemic variability, hyperglycemia risk, and treatment adherence in people with uncontrolled type 1 diabetes.

Graphene-Doped Tin Oxide Nanofibers and Nanoribbons as Gas Sensors to Detect Biomarkers of Different Diseases through the Breath.

This work presents the development of tin oxide nanofibers (NFs) and nanoribbons (NRs) sensors with graphene as a dopant for the detection of volatile organic compounds (VOCs) corresponding to different chronic diseases (asthma, chronic obstructive pulmonary disease, cystic fibrosis or diabetes). This research aims to determine the ability of these sensors to differentiate between gas samples corresponding to healthy people and patients with a disease. The nanostructures were grown by electrospinning and deposited on silicon substrates with micro-heaters integrated. The morphology of NFs and NRs was characterized by Scanning Electron Microscopy (SEM). A gas line was assembled and programmed to measure a wide range of gases (ethanol, acetone, NO and CO) at different concentrations simulating human breath conditions. Measurements were made in the presence and absence of humidity to evaluate its effect. The sensors were able to differentiate between the concentrations corresponding to a healthy person and a patient with one of the selected diseases. These were sensitive to biomarkers such as acetone and ethanol at low operating temperatures (with responses above 35%). Furthermore, CO and NO response was at high temperatures (above 5%). The sensors had a rapid response, with times of 50 s and recovery periods of about 10 min.